Clinical Trial Update: Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation [Phase 2]

View source ↗

Summary

Phase 2 trial update on aerosolized vancomycin for MRSA pneumonia in mechanically ventilated patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Pneumonia
• Pneumonia
• Staphylococcal Pneumonia

Drugs mentioned

• vancomycin (aerosolized) (vancomycin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Pneumonia, Staphylococcal, Methicillin-Resistant Staphylococcus Aureus | Phase 2 | Status: COMPLETED